ParadigmIT

ParadigmIT is a global technology solutions provider that has been setting trends in global delivery practices since its establishment in 1998. The company's focus on delivering customer value through high-quality and cost-efficient solutions has earned it a strong reputation in the industry, with a client base that includes Fortune 500 companies and government sectors. With multiple business units managing different lines of businesses in Clinical Trial Services, Application Development/Maintenance, Large scale onsite deployment projects, Staffing, and Staff Augmentation across India & USA, ParadigmIT offers a comprehensive range of IT solutions from strategy consulting to implementation and maintenance. The company's Off-shore development center boasts certifications in CMMI Level 5, ISO 9001, and ISMS 27001, along with a robust BCP/DR site, ensuring a high level of quality and security in its operations. In the Life sciences division, ParadigmIT's flagship Clinical trial services practice offers solutions & services to global Pharmaceutical, Biological, and Device organizations, with a focus on EDC build and CDM process automations to improve data delivery quality and TAT in the trial conduct phase. Notably, ParadigmIT has a strong alliance with Medidata (now Dassault Systems), a leading EDC platform solution provider, which enables the company to successfully implement Medidata’s products for complex mega-trials. Furthermore, the company is working on an innovative Study build implementation approach aimed at delivering faster and higher quality clinical data to its clients. With its Application Services & Systems Integrations division, ParadigmIT delivers IT solutions to its clients, showcasing its versatility and expertise in the industry. As the company continues to expand its global footprint and enhance its offerings, it presents an attractive opportunity for potential investors seeking to capitalize on the evolving landscape of information technology.